The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance-Reference-Cited by-同舟云学术

The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance

Published:2022-11-24 Issue:6 Volume:18 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Frost Isabel¹²,Balachandran Anand³,Paulin-Deschenaux Sarah³,Sati Hatim⁴,Hasso-Agopsowicz Mateusz¹^ORCID

Affiliation:

1. Immunization, Vaccines & Biologicals, UHC/Life Course, World Health Organization, Geneva, Switzerland

2. Imperial College London, London, UK

3. Surveillance, Prevention and Control Department, AMR Division, World Health Organization, Geneva, Switzerland

4. Global Coordination and Partnership Department, AMR Division, World Health Organization, Geneva, Switzerland

Funder

Bill and Melinda Gates Foundation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2022.2145069

Reference27 articles.

1. World Health Organization (WHO). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020 [Internet]. 2020. https://www.who.int/glass/resources/publications/early-implementation-report-2020/en/.

2. Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action

3. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

4. Drug-Resistant Infections

5. Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60 to 85 years in a randomized, double-blind, phase 1 study.;Journal of Infection and Chemotherapy;2024-09

2. Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance;ELIFE;2024

3. Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance;eLife;2024-07-24

4. Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance;eLife;2024-07-24

5. Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance;2024-06-19